Literature DB >> 6930543

Evaluation of the binding of serotonin by isolated CNS acidic lipids.

J R Yandrasitz, R M Cohn, B Masley, D DelRowe.   

Abstract

Binding of serotonin by rat lipids was examined in an organic solvent-aqueous partition system. Only phospholipids and sulfatide were found to have appreciable activity; this technique was unsuitable for gangliosides due to their poor extractibility. Binding by phospholipid was abolished and that by sulfatide was greatly inhibited by increasing ionic strength in the aqueous phase. At an ionic strength of 0.3 M the apparent affinity of sulfatide for serotonin was about 3 X 10(3) M. Both tryptamine and 5-methoxytryptamine were much more effective than serotonin in inhibiting the binding of radioactive serotonin, suggesting that the observed binding is simply a charge neutralization with little specificity. Binding of serotonin by mixed brain gangliosides was examined in an equilibrium dialysis system. Without adequate precautions, the chemical lability of serotonin was found to produce spurious data when binding was assessed by the distribution of radiolabel. Binding of serotonin by ganglioside was also greatly inhibited by increasing ionic strength: at 0.3 M an apparent affinity of about 10(3) M was found. While dopamine did not inhibit the binding of radioactive serotonin, tryptamine, 5-methoxytryptamine, and serotonin were equally effective inhibitors.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6930543     DOI: 10.1007/bf00964984

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  21 in total

1.  SEROTONIN RECEPTORS. IV. SPECIFIC DEFICIENCY OF RECEPTORS IN GALACTOSE POISONING AND ITS POSSIBLE RELATIONSHIP TO THE IDIOCY OF GALACTOSEMIA.

Authors:  D W WOOLLEY; B W GOMMI
Journal:  Proc Natl Acad Sci U S A       Date:  1964-07       Impact factor: 11.205

2.  METHODS FOR METHANOLYSIS OF SPHINGOLIPIDS AND DIRECT DETERMINATION OF LONG-CHAIN BASES BY GAS CHROMATOGRAPHY.

Authors:  R C GAVER; C C SWEELEY
Journal:  J Am Oil Chem Soc       Date:  1965-04       Impact factor: 1.849

3.  Serotonin receptors. II. Calcium transport by crude and purified receptor.

Authors:  D W WOOLLEY; N K CAMPBELL
Journal:  Biochim Biophys Acta       Date:  1960-06-03

4.  Interactions between 5-hydroxytryptamine and platelet lipid fractions.

Authors:  A J Marcus; L B Safier; H L Ullman
Journal:  Ciba Found Symp       Date:  1975

5.  The binding of 5-hydroxytryptamine to acidic lipids in isobutanol.

Authors:  D A Johnson; T M Cho; H H Loh
Journal:  J Neurochem       Date:  1977-12       Impact factor: 5.372

6.  Subcellular distribution and chemical nature of the receptor for 5-hydroxytryptamine in the central nervous system.

Authors:  S Fiszer; E De Robertis
Journal:  J Neurochem       Date:  1969-08       Impact factor: 5.372

7.  A nuclear magnetic resonance study of the interaction of serotonin with gangliosides.

Authors:  K S Krishnan; P Balaram
Journal:  FEBS Lett       Date:  1976-04-01       Impact factor: 4.124

8.  Glucose release from liposomes containing gangliosides or other membrane lipids induced by biogenic amines and myelin basic protein.

Authors:  B Maggio; M G Mestrallet; F A Cumar; R Caputto
Journal:  Biochem Biophys Res Commun       Date:  1977-08-22       Impact factor: 3.575

9.  Serotonin binding to nerve ending particles and other preparations from rat brain.

Authors:  R M Marchbanks
Journal:  J Neurochem       Date:  1966-12       Impact factor: 5.372

10.  Rapid, sensitive spectrophotometric method for quantitative determination of sulfatides.

Authors:  E L Kean
Journal:  J Lipid Res       Date:  1968-05       Impact factor: 5.922

View more
  2 in total

1.  Ca2+-induced effect on mechanical properties of sulfatide-incorporated vesicles.

Authors:  Jin-Won Park
Journal:  J Membr Biol       Date:  2010-11-19       Impact factor: 1.843

2.  Disease-modifying effects of ganglioside GM1 in Huntington's disease models.

Authors:  Melanie Alpaugh; Danny Galleguillos; Juan Forero; Luis Carlos Morales; Sebastian W Lackey; Preeti Kar; Alba Di Pardo; Andrew Holt; Bradley J Kerr; Kathryn G Todd; Glen B Baker; Karim Fouad; Simonetta Sipione
Journal:  EMBO Mol Med       Date:  2017-11       Impact factor: 12.137

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.